Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05470751 · ClinicalTrials.gov registry record

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

A clinical trial of Multiple Sclerosis and Parkinson Disease, sponsored by ConvaTec.

Completed
Registry status
72
Enrollment target
16
Study locations

NCT05470751: Completed study of Multiple Sclerosis and Parkinson Disease, sponsored by ConvaTec.

NCT05470751 is a study of Multiple Sclerosis and Parkinson Disease that has completed, run by ConvaTec. The registered enrollment target is 72 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (88% lower). The trial reports 16 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05470751, a study of Multiple Sclerosis and Parkinson Disease, has completed, sponsored by ConvaTec.

COMPLETED
Registry status
72 participants
Enrollment target
16
Study locations

Study Summary

Male self catherterisng observational study.

Primary Outcome

To assess difficulty during catheterisation and quality of life using the ICDQ and ISC-Q

Conditions Studied

Multiple Sclerosis Parkinson Disease Spinal Cord Injuries Lower Urinary Tract Symptoms Bladder Outlet Obstruction Enlarged Prostate With Lower Urinary Tract Symptoms Cauda Equina Syndrome Detrusor Underactivity

Interventions

  • DEVICE Intermittent self-catheterisation

Study Locations (16)

Other

  • Centre Hospitalier Universitaire de Bordeaux | Pellegrin Hospital - Urology Department - Bordeaux
  • Assistance Publique Hopitaux de Paris | Pitie Salpetriere University Hospital - Urology Department - Paris
  • Guy's and St Thomas' Foundation Trust | Guy's Hospital - Transplant, Renal and Urology Research - London
  • King's College Hospital NHS Foundation Trust | King's College Hospital - Renal Research Department - London

Essex

  • Broomfield Hospital - Chelmsford
  • Mid and South Essex NHS Foundation Trust | Southend University Hospital - Research & Development - Southend-on-Sea

New Jersey

  • Kessler Institute for Rehabilitation - West Orange

Pennsylvania

  • Trustees of The University of Pennsylvania | Penn Urology Washington Square - Philadelphia

Cheshire

  • Stockport NHS Foundation Trust | Stepping Hill Hospital - Research and Innovation Department - Stockport

Gwent

  • Aneurin Bevan University Health Board | Royal Gwent Hospital - Clinical Research Centre - Newport

Hampshire

  • Southampton General Hospital - Southampton

Kent

  • Kent and Canterbury Hospital | Renal Research Delivery Team - Canterbury

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2023-02-02
Est. Completion 2024-04-06
ConvaTec

17 total trials

What the finished NCT05470751 record still lists

NCT05470751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (88% lower).

The record links to 8 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Intermittent self-catheterisation is the first listed.

NCT05470751 lists 16 locations in 12 states (Other, Essex, New Jersey).

Frequently Asked Questions

What is clinical trial NCT05470751 about?

NCT05470751 is a clinical study titled "GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology". Male self catherterisng observational study.

What is the current status of trial NCT05470751?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2023-02-02. Estimated completion is 2024-04-06.

What conditions does trial NCT05470751 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Parkinson Disease, Spinal Cord Injuries, Lower Urinary Tract Symptoms, Bladder Outlet Obstruction.

What interventions are being tested in trial NCT05470751?

The interventions under investigation include: Intermittent self-catheterisation (DEVICE).

Who is sponsoring clinical trial NCT05470751?

This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05470751 being conducted?

This trial has 16 study locations across New Jersey, Pennsylvania, Cheshire, Essex, Gwent. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05470751's enrollment target sits among peer trials

72 152nd of 315 higher than 163 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05470751, the US trial registry maintained by the National Library of Medicine. NCT05470751 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.